Form 4 holding
Chief Development Officer
SpringWorks Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 233,363
- Estimated value
- $9,691,565
- Report date
- 08 Jan 2024
- Price
- $41.53
- Ownership
- Direct
L. Mary Smith - Chief Development Officer at SpringWorks Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Development Officer
- Issuer ticker
- SWTX
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by L. Mary Smith since 13 Sep 2025
Reported holdings for L. Mary Smith in SpringWorks Therapeutics, Inc.
Form 4 holding
Chief Development Officer
SpringWorks Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 60,000
- Estimated value
- Report date
- 04 Jan 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for L. Mary Smith in SpringWorks Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.